HomepageKVUE • NYSE
add
Kenvue Inc
$Â 23,82
Na sluitingstijd:(0,13%)+0,030
$Â 23,85
Gesloten: 15 nov, 19:33:14 GMT-5 · USD · NYSE · Disclaimer
Vorige slotkoers
$Â 23,61
Dag-range
$Â 23,44 - $Â 24,13
Jaar-range
$Â 17,67 - $Â 24,13
Beurswaarde
45,62Â mld. USD
Gem. volume
15,52Â mln.
Koers/winst
43,02
Dividendrendement
3,44%
Primaire beurs
NYSE
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 3,90Â mld. | -0,41% |
Bedrijfskosten | 1,51Â mld. | 7,69% |
Netto inkomsten | 383,00Â mln. | -12,56% |
Netto winstmarge | 9,82 | -12,24% |
Winst per aandeel | 0,28 | -9,68% |
EBITDA | 956,00Â mln. | -4,30% |
Effectief belastingtarief | 33,62% | — |
Balans
Totale activa
Totale passiva
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 1,06Â mld. | -0,47% |
Totale activa | 26,92Â mld. | -0,56% |
Totale passiva | 16,28Â mld. | 0,60% |
Totaal aandelenvermogen | 10,64 mld. | — |
Uitstaande aandelen | 1,92 mld. | — |
Koers-boekwaardeverhouding | 4,25 | — |
Rendement op activa | 7,25% | — |
Rendement op kapitaal | 10,12% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 383,00Â mln. | -12,56% |
Operationele kasstroom | 249,00Â mln. | -63,06% |
Kasstroom uit beleggingen | -56,00Â mln. | 46,67% |
Kasstroom uit financiering | -162,00Â mln. | 77,69% |
Nettomutatie in liquide middelen | 43,00Â mln. | 125,44% |
Vrije kasstroom | 368,25Â mln. | -51,28% |
Over
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue is the proprietor of well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine.
Kenvue is incorporated under the Delaware General Corporation Law and is headquartered in the Skillman section of Montgomery Township, New Jersey, with plans to relocate its global headquarters to Summit, New Jersey. Before the spin-off, Johnson & Johnson's consumer health division was based in Skillman, even as its pharmaceutical division and medical technologies division, as well as the overall company headquarters, were located in nearby New Brunswick, New Jersey. Wikipedia
Opgericht
23 feb 2022
Hoofdvestiging
Website
Werknemers
22.000